Literature DB >> 15998293

Syntaxin 5 interacts specifically with presenilin holoproteins and affects processing of betaAPP in neuronal cells.

Kei Suga1, Ayako Saito, Takami Tomiyama, Hiroshi Mori, Kimio Akagawa.   

Abstract

The specific roles of syntaxin 5 (Syx 5) in the interaction with presenilin (PS) and the accumulation of beta-amyloid precursor protein (betaAPP), as well as the secretion of beta-amyloid peptide (Abeta peptide) were examined in NG108-15 cells. Syx 5, which localizes from the endoplasmic reticulum (ER) to the Golgi, bound to PS holoproteins, while the other Syxs studied did not. Among familial Alzheimer's disease (FAD)-linked PS mutants, PS1deltaE9, which lacks the endoproteolytic cleavage site, showed markedly decreased binding to Syx 5. The interaction domains in Syx 5 were mapped to the transmembrane region and to the cytoplasmic region containing the alpha-helical domains, which are distinct from the H3 (SNARE motif). Among all of the Syxs examined, only overexpression of Syx 5 resulted in the accumulation of betaAPP in the ER to cis-Golgi compartment, an attenuation of the amount of the C-terminal fragment (APP-CTF) of betaAPP, and a reduction in the secretion of Abeta peptides. Furthermore, co-expression of Syx 5 with C99 resulted in an increase in APP-CTF and suppressed Abeta secretion. Taken together, these results indicate that Syx 5 may play a specific role in the modulation of processing and/or trafficking of FAD-related proteins in neuronal cells by interaction with PS holoproteins in the early secretory compartment of neuronal cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15998293     DOI: 10.1111/j.1471-4159.2005.03210.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  13 in total

Review 1.  The study of Golgi apparatus in Alzheimer's disease.

Authors:  Zhiping Hu; Liuwang Zeng; Zhiling Huang; Jie Zhang; Ting Li
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 3.996

2.  Induction of heat shock proteins in differentiated human and rodent neurons by celastrol.

Authors:  Ari M Chow; Ian R Brown
Journal:  Cell Stress Chaperones       Date:  2007       Impact factor: 3.667

Review 3.  The Role of Presenilin in Protein Trafficking and Degradation-Implications for Metal Homeostasis.

Authors:  M A Greenough
Journal:  J Mol Neurosci       Date:  2016-08-25       Impact factor: 3.444

4.  Papillomavirus infection requires gamma secretase.

Authors:  Balasubramanyam Karanam; Shiwen Peng; Tong Li; Christopher Buck; Patricia M Day; Richard B S Roden
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

Review 5.  Conserved Oligomeric Golgi and Neuronal Vesicular Trafficking.

Authors:  Leslie K Climer; Rachel D Hendrix; Vladimir V Lupashin
Journal:  Handb Exp Pharmacol       Date:  2018

6.  The COG complex, Rab6 and COPI define a novel Golgi retrograde trafficking pathway that is exploited by SubAB toxin.

Authors:  Richard D Smith; Rose Willett; Tetyana Kudlyk; Irina Pokrovskaya; Adrienne W Paton; James C Paton; Vladimir V Lupashin
Journal:  Traffic       Date:  2009-07-21       Impact factor: 6.215

Review 7.  The role of presenilin and its interacting proteins in the biogenesis of Alzheimer's beta amyloid.

Authors:  Giuseppe Verdile; Samuel E Gandy; Ralph N Martins
Journal:  Neurochem Res       Date:  2006-08-31       Impact factor: 3.996

8.  Data supporting ER stress response in NG108-15 cells involves upregulation of syntaxin 5 expression and reduced amyloid β peptide secretion.

Authors:  Kei Suga; Ayako Saito; Kimio Akagawa
Journal:  Data Brief       Date:  2015-11-07

9.  Data for the effects of ER and Golgi stresses on the ER-Golgi SNARE Syntaxin5 expression and on the βAPP processing in cultured hippocampal neurons.

Authors:  Kei Suga; Ayako Saito; Tatsuya Mishima; Kimio Akagawa
Journal:  Data Brief       Date:  2015-09-04

Review 10.  gamma-Secretase: a multifaceted regulator of angiogenesis.

Authors:  Michael E Boulton; Jun Cai; Maria B Grant
Journal:  J Cell Mol Med       Date:  2008-02-08       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.